Affinity Asset Advisors, LLC has updated its ownership stake in Verrica Pharmaceuticals Inc., now holding approximately 4.99% of the company's common stock. This strategic move indicates a continued interest in the pharmaceutical preparations sector, which is characterized by ongoing innovation and competition.

Affinity Asset Advisors, LLC, a Delaware limited liability company, is an investment management firm based in New York. The company focuses on managing assets and investments, particularly in the healthcare sector. The firm filed its latest report on November 13, 2026, under the Schedule 13G/A form, which is used to report beneficial ownership of securities.

According to the filing, Affinity Asset Advisors beneficially owns 865,488 shares of Verrica Pharmaceuticals as of September 30, 2026. This includes 176,834 shares that are issuable upon the exercise of warrants. The filing states, "The securities reported herein are directly held by Affinity Healthcare Fund, LP (the 'Fund')." Affinity Asset Advisors serves as the investment manager for the Fund, which gives it the power to vote and invest on behalf of the Fund.

This update in ownership may affect corporate governance at Verrica Pharmaceuticals. With Affinity Asset Advisors now holding a significant stake, the firm could influence decisions related to the company's strategic direction and operations. Additionally, this filing reflects a trend of investment firms increasing their stakes in pharmaceutical companies, which can lead to shifts in market dynamics.

As of now, the filing does not specify what actions may follow this update. Investors and analysts will be watching closely to see how this stake may impact Verrica Pharmaceuticals in the future.